CompletedPhase 4

Exercise Training in Chagas Cardiomyopathy

Brazil37 participantsStarted 2007-03

Plain-language summary

The benefits of exercise training in heart failure are well established. Its effects, however, have not been evaluated in Chagas cardiomyopathy (ChC). The investigators hypothesis is that the exercise training may improve functional capacity, quality of life (QoL), and reduce brain natriuretic peptide (BNP) levels in patients with ChC.

Who can participate

Age range30 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Chronic Chagas dilated cardiomyopathy, defined by the echocardiography finding of a dilated left ventricle with moderate or severe impaired left ventricular systolic function (left ventricular ejection fraction ≤ 45%). * To be clinically stable for at least 3 months * To have sinus rhythm * To be under standard medical therapy use at the time. Exclusion Criteria: * Inability to attend regular exercise training * The presence of a pacemaker, associated cardiac or systemic diseases * Practitioners of regular physical activity

What they're measuring

Functional capacity

Timeframe: 12 weeks

Functional class

Timeframe: 12 weeks

Health related quality of life

Timeframe: 12 weeks

BNP levels

Timeframe: 12 weeks

Trial details

NCT IDNCT01006473

SponsorFederal University of Minas Gerais

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-03

View on ClinicalTrials.gov More Chagas Disease trials